Discover the latest software purchases and digital transformation initiatives being undertaken by Actelion Pharmaceuticals Ltd and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2624 Actelion Pharmaceuticals Ltd employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Actelion Pharmaceuticals Ltd has purchased the following applications: BSI CTMS for in 2006 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Actelion Pharmaceuticals Ltd is running and its propensity to invest more and deepen its relationship with BSI Business Systems Integration or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Actelion Pharmaceuticals Ltd revenues, which have grown to $2.49 billions in 2019, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Actelion Pharmaceuticals Ltd intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
|Vendor||Old Product||New Product||Category||Market||Users||VAR/SI||When||Live|
|BSI Business Systems Integration||Legacy Applications||BSI CTMS||Clinical Trial Management Software||ERP Services and Operations||100||n/a||2006||2006|
|First Name||Last Name||Title||Phone|